Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 2 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 1 % of short-term debt in 2024; threshold 65 %.
Financials
Financial year 2024
AMPHIKTION from Brussel, company number BE0803632924, closed financial year 2024 with a result of € 33,500 after tax. For that financial year AMPHIKTION recorded a gross margin of € 200,476 and equity of € -196,258. Compared with financial year 2023, the result moved from € -269,758 to € 33,500. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 17, 2025.
€ -196,258
▼ € 366,500 vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 33,500
▲ still € 269,758 loss in 2023
Profit after tax over the fiscal year.
€ 3,641
▼ 34% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € -236,258.
People and assets in 2024
€ 3,931
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 1.5 million
€ 92,278 is repaid this year. At this pace the long-term loan is gone in ≈ 16 years.
€ 14,016
▼ 92% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 5,624
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|
| Gross margin | € 8,081 | € 200,476 | ▲ € 192,395 |
| Profit after taxes | € -269,758 | € 33,500 | ▲ € 303,258 |
| Equity | € 170,242 | € -196,258 | ▼ € 366,500 |
| Total debts | € 1,681,058 | € 1,760,332 | ▲ 5% |
| Cash | € 5,516 | € 3,641 | ▼ 34% |
| Land & buildings | € 1,837,319 | € 1,506,480 | ▼ 18% |
| Retained profit | € -269,758 | € -236,258 | ▲ € 33,500 |
| Bank debt | € 1,485,419 | € 1,484,907 | |
| Balance sheet total | € 1,851,300 | € 1,564,074 | ▼ 16% |
Key figures of AMPHIKTION, fiscal years 2023 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to AMPHIKTION?
What happened at AMPHIKTION in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 33,500. filed late Source: NBB ↗
- New establishment in Brussel. KBO
- PHARMALEGAL BV became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 269,758 loss in 2023 to € 33,500 profit in 2024.
Best year ever: 2024, with € 33,500 profit.
A new publication or filing at AMPHIKTION? We notify you, reason included.
Follow AMPHIKTIONDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind AMPHIKTION is PHARMALEGAL BV. PHARMALEGAL BV is also behind ZORGPUNT, Lynxcare Clinical Informatics, ASYLIA DIAGNOSTICS, Curaevia and Thuiszorg Cooperatie.
Directors
According to the 2024 annual accounts
Director · represented by DE FEU GEORGES
Also active at: ZORGPUNT, Lynxcare Clinical Informatics, ASYLIA DIAGNOSTICS, Curaevia, Thuiszorg Cooperatie, PharmaBXL
since 2023
Establishments
Establishment units
Physical locations of this company
Zavelput 17
1000 Brussel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
All companies at this address →Association d'Entraide homophile - Association pour la Défense des Homophiles
PHARMACIE BOTANIQUE
€ 236,541 gross margin · 2023
PharmaBXL same network
€ 436,169 gross margin · 2024
PharmaPROP.BXL
€ 50,325 gross margin · 2024
PharmaOPS.BXL
€ 596,330 gross margin · 2024
+1 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0803.632.924
- VAT number
- BE 0803.632.924
- Registered office
- Zavelput 17, 1000 Brussel
- Names & denominations
- AMPHIKTION
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 5 July 2023
- Peppol
- Active · Active since 25 Sept 2026
- Activities · NACE
Activiteiten van holdings
Holdings
Handel in eigen onroerend goed